
Alvotech Disputes AbbVie’s Recent Allegations
REYKJAVIK, Iceland–(BUSINESS WIRE)–Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab). Alvotech will vigorously defend against these allegations. […]
